Analysis of long noncoding RNA-associated competing endogenous RNA network in glucagon-like peptide-1 receptor agonist-mediated protection in β cells

被引:8
作者
Cui, Li-Juan [1 ]
Bai, Tao [2 ]
Zhi, Lin-Ping [1 ]
Liu, Zhi-Hong [3 ]
Liu, Tao [4 ]
Xue, Huan [1 ]
Yang, Huan-Huan [1 ]
Yang, Xiao-Hua [1 ]
Zhang, Min [5 ]
Niu, Ya-Ru [6 ]
Liu, Yun-Feng [2 ]
Zhang, Yi [1 ]
机构
[1] Shanxi Med Univ, Dept Pharmacol, Basic Med Coll, 56 Xinjian South Rd, Taiyuan 030001, Shanxi, Peoples R China
[2] Shanxi Med Univ, Clin Hosp 1, Dept Endocrinol, Taiyuan 030001, Shanxi, Peoples R China
[3] Shanxi Med Univ, Clin Hosp 1, Dept Resp Med, Taiyuan 030001, Shanxi, Peoples R China
[4] Shanxi Bethune Hosp, Dept Gen Surg, Taiyuan 030006, Shanxi, Peoples R China
[5] Shanxi Med Univ, Coll Pharm, Taiyuan 030001, Shanxi, Peoples R China
[6] Shanxi Med Univ, Clin Med Coll 2, Taiyuan 030001, Shanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Type; 2; diabetes; beta cell; Long noncoding RNA; Competing endogenous RNA; Co-expression analysis; Glucagon-like peptide-1 receptor agonist; INSULIN-SECRETION; EXPRESSION; APOPTOSIS; ACTIVATION; DYSFUNCTION;
D O I
10.4239/wjd.v11.i9.374
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
BACKGROUND Long noncoding RNAs (lncRNAs) and mRNAs are widely involved in various physiological and pathological processes. The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) is a novel therapeutic strategy that could promote insulin secretion and decrease the rate of beta-cell apoptosis in type 2 diabetes mellitus (T2DM) patients. However, the specific lncRNAs and mRNAs and their functions in these processes have not been fully identified and elucidated. AIM To identify the lncRNAs and mRNAs that are involved in the protective effect of GLP-1RA in beta cells, and their roles. METHODS Rat gene microarray was used to screen differentially expressed (DE) lncRNAs and mRNAs in beta cells treated with geniposide, a GLP-1RA. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to assess the underlying functions of DE mRNAs. Hub mRNAs were filtered using the STRING database and the Cytoscape plugin, CytoHubba. In order to reveal the regulatory relationship between lncRNAs and hub mRNAs, their co-expression network was constructed based on the Pearson coefficient of DE lncRNAs and mRNAs, and competing endogenous RNA (ceRNA) mechanism was explored through miRanda and TargetScan databases. RESULTS We identified 308 DE lncRNAs and 128 DE mRNAs with a fold change filter of >= 1.5 andPvalue < 0.05. GO and KEGG pathway enrichment analyses indicated that the most enriched terms were G-protein coupled receptor signaling pathway, inflammatory response, calcium signaling pathway, positive regulation of cell proliferation, and ERK1 and ERK2 cascade.Pomc,Htr2a, andAgtr1awere screened as hub mRNAs using the STRING database and the Cytoscape plugin, CytoHubba. This result was further verified using SwissTargetPrediction tool. Through the co-expression network and competing endogenous (ceRNA) mechanism, we identified seven lncRNAs (NONRATT027738, NONRATT027888, NONRATT030038,etc.) co-expressed with the three hub mRNAs (Pomc, Htr2a, and Agtr1a) based on the Pearson coefficient of the expression levels. These lncRNAs regulated hub mRNA functions by competing with six miRNAs (rno-miR-5132-3p, rno-miR-344g, rno-miR-3075,etc.)viathe ceRNA mechanism. Further analysis indicated that lncRNA NONRATT027738 interacts with all the three hub mRNAs, suggesting that it is at a core position within the ceRNA network. CONCLUSION We have identified key lncRNAs and mRNAs, and highlighted here how they interact through the ceRNA mechanism to mediate the protective effect of GLP-1RA in beta cells.
引用
收藏
页码:374 / 390
页数:17
相关论文
共 44 条
[1]
Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes [J].
Bennet, H. ;
Balhuizen, A. ;
Medina, A. ;
Nitert, M. Dekker ;
Laakso, E. Ottosson ;
Essen, S. ;
Spegel, P. ;
Storm, P. ;
Krus, U. ;
Wierup, N. ;
Fex, M. .
PEPTIDES, 2015, 71 :113-120
[2]
β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes [J].
Butler, AE ;
Janson, J ;
Bonner-Weir, S ;
Ritzel, R ;
Rizza, RA ;
Butler, PC .
DIABETES, 2003, 52 (01) :102-110
[3]
Identification of microRNAs expressed highly in pancreatic islet-like cell clusters differentiated from human embryonic stem cells [J].
Chen, Bo-Zhi ;
Yu, Sung-Liang ;
Sing, Sher ;
Kao, Li-Pin ;
Tsai, Zong-Yun ;
Yang, Pan-Chyr ;
Chen, Bai-Hsiun ;
Li, Steven Shoei-Lung .
CELL BIOLOGY INTERNATIONAL, 2011, 35 (01) :29-37
[4]
cytoHubba: identifying hub objects and sub-networks from complex interactome [J].
Chin, Chia-Hao ;
Chen, Shu-Hwa ;
Wu, Hsin-Hung ;
Ho, Chin-Wen ;
Ko, Ming-Tat ;
Lin, Chung-Yen .
BMC SYSTEMS BIOLOGY, 2014, 8
[5]
Class II Phosphoinositide 3-Kinase Regulates Exocytosis of Insulin Granules in Pancreatic β Cells [J].
Dominguez, Veronica ;
Raimondi, Claudio ;
Somanath, Sangeeta ;
Bugliani, Marco ;
Loder, Merewyn K. ;
Edling, Charlotte E. ;
Divecha, Nullin ;
da Silva-Xavier, Gabriela ;
Marselli, Lorella ;
Persaud, Shanta J. ;
Turner, Mark D. ;
Rutter, Guy A. ;
Marchetti, Piero ;
Falasca, Marco ;
Maffucci, Tania .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (06) :4216-4225
[6]
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [J].
Drucker, Daniel J. ;
Nauck, Michael A. .
LANCET, 2006, 368 (9548) :1696-1705
[7]
Discovery, characterization, and clinical development of the glucagon-like peptides [J].
Drucker, Daniel J. ;
Habener, Joel F. ;
Holst, Jens Juul .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (12) :4217-4227
[8]
Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2 [J].
Drucker, Daniel J. ;
Yusta, Bernardo .
ANNUAL REVIEW OF PHYSIOLOGY, VOL 76, 2014, 76 :561-583
[9]
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes [J].
Fu, Zhuo ;
Gilbert, Elizabeth R. ;
Liu, Dongmin .
CURRENT DIABETES REVIEWS, 2013, 9 (01) :25-53
[10]
The PLC/PKC/Ras/MEK/Kv channel pathway is involved in uncarboxylated osteocalcin-regulated insulin secretion in rats [J].
Gao, Jingying ;
Bai, Tao ;
Ren, Lele ;
Ding, Yaqin ;
Zhong, Xiangqin ;
Wang, Hui ;
Guo, Yangyan ;
Li, Jie ;
Liu, Yunfeng ;
Zhang, Yi .
PEPTIDES, 2016, 86 :72-79